The Pathogenesis and Treatment of Cardiovascular Autonomic Dysfunction in Parkinson’s Disease: What We Know and Where to GoShuzhen Zhu, Qing Wang, Xiaobo Wei et al.|Aging and Disease|2021Cited by 34
Plasma fibronectin is a prognostic biomarker of disability in Parkinson’s disease: a prospective, multicenter cohort studyShuzhen Zhu, Qing Wang, Hualin Li et al.|npj Parkinson s Disease|2025Cited by 18
Fibrinogen is an Independent Risk Factor for White Matter Hyperintensities in CADASIL but not in Sporadic Cerebral Small Vessel Disease PatientsXingfang Guo, Qing Wang, Bin Deng et al.|Aging and Disease|2021Cited by 11
A 5-Year Longitudinal, Multicentre Validation Study Assessing the Prognostic Value of Plasma Fibronectin in a Cohort of Parkinson's Disease ParticipantsShuzhen Zhu, Hualin Li, Zifeng Huang et al.|SSRN Electronic Journal|2023Cited by 0
Plasma Fibronectin is a Prognostic Biomarker of Disability in Parkinson's Disease: A Prospective, Multicenter Cohort StudyShuzhen Zhu, Hualin Li, Zifeng Huang et al.|SSRN Electronic Journal|2024Cited by 0